GRI Bio Inc.

NASDAQ: GRI · Real-Time Price · USD
1.40
-0.04 (-2.78%)
At close: Aug 15, 2025, 3:59 PM
1.44
2.86%
After-hours: Aug 15, 2025, 07:46 PM EDT

GRI Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-8.21M -13.04M -3.22M -9.3M
Depreciation & Amortization
4K 57K 50K 73K
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
-61K -479K 618K 871K
Other Non-Cash Items
40K 2.16M 567K 355K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-448K 1.68M 1.51M 563K
Operating Cash Flow
-8.61M -9.14M -1.08M -8.31M
Capital Expenditures
n/a -8K -3K n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -3.84M
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a -8K -3K -3.84M
Debt Repayment
n/a 1.25M 1.24M 244K
Common Stock Repurchased
n/a n/a -124K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-1K -2.05M 5K 15.4M
Financial Cash Flow
11.83M 10.95M 1.01M 15.75M
Net Cash Flow
3.22M 1.8M -81K n/a
Free Cash Flow
-8.61M -9.15M -1.09M -8.31M